- Home
- MRNA vs CIB Comparison
MRNA vs CIB Comparison
Compare MRNA & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | CIB |
|---|---|---|
| Founded | 2010 | 1945 |
| Country | United States | Colombia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 14.5B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MRNA | CIB |
|---|---|---|
| Price | $27.74 | $62.35 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 5 |
| Target Price | $33.91 | ★ $47.75 |
| AVG Volume (30 Days) | ★ 9.9M | 309.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 7.79% |
| EPS Growth | N/A | ★ 22.14 |
| EPS | N/A | ★ 1.96 |
| Revenue | $2,232,000,000.00 | ★ $6,289,868,892.00 |
| Revenue This Year | N/A | $32.05 |
| Revenue Next Year | $0.77 | $6.89 |
| P/E Ratio | ★ N/A | $8.73 |
| Revenue Growth | N/A | ★ 15.25 |
| 52 Week Low | $22.28 | $31.19 |
| 52 Week High | $48.92 | $65.47 |
Technical Indicators
Market Signals| Indicator | MRNA | CIB |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 55.80 |
| Support Level | $23.92 | $59.64 |
| Resistance Level | $26.00 | $65.47 |
| Average True Range (ATR) | 1.29 | 1.67 |
| MACD | 0.32 | -0.16 |
| Stochastic Oscillator | 99.82 | 46.52 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.